Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients

Abstract Introduction A new type of immune cell transplantation called allogeneic NK cell infusion is proposed as a potential universal off-the-shelf cell product for adoptive immune cell therapy in hematologic malignancies. Design A multicentral phase I non-randomized clinical trial was conducted t...

Full description

Bibliographic Details
Main Authors: Mohammad Ahmadvand, Mahdieh Shokrollahi Barough, Maryam Barkhordar, Ali Faridfar, Afshin Ghaderi, Hasan Jalaeikhoo, Mohsen Rajaienejad, Keivan Majidzadeh, Ardeshir Ghavamzadeh, Ramin Sarrami-Forooshani
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Cancer
Subjects:
Acute Myeloid Leukemia (AML)
Allogeneic NK cell therapy
Adoptive transfer
Cellular therapy
Online Access:https://doi.org/10.1186/s12885-023-11610-x

Internet

https://doi.org/10.1186/s12885-023-11610-x

Similar Items